Food and Drug Administration Revitalization Act
|Long title||An Act to amend the Federal Food, Drug,and Cosmetic Act to revitalize the Food and Drug Administration, and for other purposes.|
|Enacted by||the 101st United States Congress|
|Effective||November 28, 1990|
|Statutes at Large||104 Stat. 4583|
|Acts amended||Federal Food, Drug, and Cosmetic Act|
|Titles amended||21 U.S.C.: Food and Drugs|
|U.S.C. sections amended|
The Food and Drug Administration Revitalization Act was introduced by the 101st Congress of the United States. Senator Orrin G. Hatch was the chairperson sponsor of the federal revitalization amendment for the Food and Drug Administration.
The Title 21 amendment was signed into law on November 28, 1990 by the 43rd President of the United States George H. W. Bush.
Provisions of the Act
The Food and Drug Administration Revitalization Act of 1990 was penned with four legislative titles establishing a medium for the rejuvenation of the public health agency.
Title I: Administrative and Laboratory Facility Consolidation - 21 U.S.C. § 379b
- General Services Administration provided authority to grant contracts for consolidated Food and Drug Administration facilities. The contracts shall be granted for the design, construction, and operation of consolidated Food and Drug Administration facilities.
Title II: Recovery and Retention of Fees for FOIA Requests - 21 U.S.C. § 379c
- Charge fees shall be applied to recover reasonable costs incurred in processing Freedom of Information requests for records obtained or created under this Act.
Title III: Scientific Review Groups - 21 U.S.C. § 394
- Technical and scientific review groups shall be established as needed to perform functions of the Food and Drug Administration.
Title IV: Automation of FDA - 21 U.S.C. § 379d
- Agency shall automate appropriate activities of the Food and Drug Administration to ensure timely review of regulatory activities under this Act.
- "Food and Drug Administration: Insufficient Planning for Field Laboratory Consolidation Decisions" (PDF). U.S. GAO ~ HRD-88-21. U.S. Government Accountability Office. December 4, 1987.
- "FDA Resources: Comprehensive Assessment of Staffing, Facilities, and Equipment Needs" (PDF). U.S. GAO ~ HRD-89-142. U.S. Government Accountability Office. September 15, 1989.
- "FDA Laboratories: Magnitude of Benefits Associated With Consolidation Is Questionable" (PDF). U.S. GAO ~ HEHS-96-30. U.S. Government Accountability Office. March 19, 1996. OCLC 34612714.